Resolute Financial’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$13.3K Hold
1,240
0.01% 111
2022
Q3
$18K Buy
1,240
+40
+3% +$581 0.02% 102
2022
Q2
$43K Buy
+1,200
New +$43K 0.04% 119